PolyPid Ltd.
PYPDNASDAQHealthcare● Active
$4.62
+$0.12(+2.67%)
Market Cap$47081958
P/E Ratio—
52W High$5.21
52W Low$2.77
PolyPid Ltd. (PYPD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PYPD · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.35
Est. -$0.47 · +25.5%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
PYPD reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.32 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 13, 2026 | -$0.47 | -$0.35 | +25.5% | — | — | — |
| ▼ Q1 FY2026 | Feb 11, 2026 | -$0.34 | -$0.41 | -20.6% | — | — | — |
| ▲ Q4 FY2025 | Nov 12, 2025 | -$0.54 | -$0.37 | +31.5% | — | — | — |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.53 | -$0.78 | -47.2% | — | — | — |
| ▲ Q2 FY2025 | May 14, 2025 | -$0.80 | -$0.70 | +12.5% | — | — | — |
| ▼ Q1 FY2025 | Feb 12, 2025 | -$0.90 | -$1.13 | -25.6% | — | — | — |
| ▼ Q4 FY2024 | Nov 13, 2024 | -$1.07 | -$1.22 | -14.0% | — | — | — |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.32
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Beat
EPS Actual
-$0.35
EPS Est.
-$0.47
EPS Surpr.
+25.5%
Revenue
—
Q1 FY2026
Feb 11, 2026Miss
EPS Actual
-$0.41
EPS Est.
-$0.34
EPS Surpr.
-20.6%
Revenue
—
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
-$0.37
EPS Est.
-$0.54
EPS Surpr.
+31.5%
Revenue
—
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$0.78
EPS Est.
-$0.53
EPS Surpr.
-47.2%
Revenue
—
Q2 FY2025
May 14, 2025Beat
EPS Actual
-$0.70
EPS Est.
-$0.80
EPS Surpr.
+12.5%
Revenue
—
Q1 FY2025
Feb 12, 2025Miss
EPS Actual
-$1.13
EPS Est.
-$0.90
EPS Surpr.
-25.6%
Revenue
—
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$1.22
EPS Est.
-$1.07
EPS Surpr.
-14.0%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.24 | $-0.24 | $-0.24 | 1 |
| Q3 FY2027 | $-0.25 | $-0.25 | $-0.25 | 1 |
| Q2 FY2027 | $-0.26 | $-0.26 | $-0.26 | 1 |
| Q1 FY2027 | $-0.32 | $-0.32 | $-0.32 | 1 |
| Q4 FY2026 | $-0.34 | $-0.34 | $-0.34 | 1 |
| Q3 FY2026 | $-0.39 | $-0.31 | $-0.23 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 13, 2026 | +25.5% | $4.56 | $4.22 | -7.46% |
| ▼ Q1 FY2026 | Feb 11, 2026 | -20.6% | $4.68 | $4.62 | -1.28% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +31.5% | $3.76 | $3.75 | -0.27% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -47.2% | $3.42 | $3.49 | +2.05% |
| ▲ Q2 FY2025 | May 14, 2025 | +12.5% | $2.71 | $2.90 | +7.01% |
| ▼ Q1 FY2025 | Feb 12, 2025 | -25.6% | $2.89 | $2.97 | +2.77% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -14.0% | $3.50 | $3.40 | -2.86% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +17.2% | $3.56 | $3.49 | -1.97% |
Q2 FY2026-7.46%
Report Date
May 13, 2026
EPS Beat/Miss
+25.5%
Price Before
$4.56
Price After
$4.22
Q1 FY2026-1.28%
Report Date
Feb 11, 2026
EPS Beat/Miss
-20.6%
Price Before
$4.68
Price After
$4.62
Q4 FY2025-0.27%
Report Date
Nov 12, 2025
EPS Beat/Miss
+31.5%
Price Before
$3.76
Price After
$3.75
Q3 FY2025+2.05%
Report Date
Aug 13, 2025
EPS Beat/Miss
-47.2%
Price Before
$3.42
Price After
$3.49
Q2 FY2025+7.01%
Report Date
May 14, 2025
EPS Beat/Miss
+12.5%
Price Before
$2.71
Price After
$2.90
Q1 FY2025+2.77%
Report Date
Feb 12, 2025
EPS Beat/Miss
-25.6%
Price Before
$2.89
Price After
$2.97
Q4 FY2024-2.86%
Report Date
Nov 13, 2024
EPS Beat/Miss
-14.0%
Price Before
$3.50
Price After
$3.40
Q3 FY2024-1.97%
Report Date
Aug 14, 2024
EPS Beat/Miss
+17.2%
Price Before
$3.56
Price After
$3.49
Avg Beat Reaction-0.67%
Avg Miss Reaction+0.17%
Beat Rate4 / 8 quarters
Largest Move-7.46% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PYPD ends December
PolyPid Ltd. (PYPD) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.35 — beating the analyst consensus of $-0.47 by +25.5%. The next PYPD earnings date is expected around September 1, 2026.
Each quarter, investors track PYPD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PYPD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PYPD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PYPD earnings · 5 questionsPolyPid Ltd.'s next earnings report is expected around September 1, 2026. PYPD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PYPD historically reports after market close (AMC).
PYPD earnings datewhen is PYPD earningsPYPD next earnings datewhen does PYPD report earningsPYPD earnings calendar
▸ Source: FMP · PolyPid Ltd. SEC filings · US GAAP · PolyPid Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026